The Impact of Disease Duration on Sex Differences in Cardiometabolic Risk Factors in Type 2 Diabetic Patients on Metformin-glimepiride Oral Therapy
Martin Awe Akilla, Moses Banyeh & Ignatius Abowini Awinibuno Nchor · Asian Journal of Research and Reports in Endocrinology · 2023
Aims: Patients with type 2 diabetes mellitus (T2DM) are commonly treated with metformin-glimepiride combination therapy. The relationship between disease duration and cardiometabolic risk factors among T2DM patients on metformin-glimepiride combination therapy may be moderated by...
Open access
Research Article